[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global and China Endothelin Receptor Antagonist Market Research Report Forecast 2017 to 2022

December 2017 | 118 pages | ID: G2FE986C478EN
S&P Consulting

US$ 2,160.00 US$ 2,700.00 -20 %

E-mail Delivery (PDF), E-mail Delivery (Word), E-mail Delivery (Excel), E-mail Delivery (PowerPoint)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Delivery of the Report will take 2-3 working days once order is placed.

The Global and China Endothelin Receptor Antagonist Market Research Report Forecast 2017-2022is a valuable source of insightful data for business strategists. It provides the Endothelin Receptor Antagonist industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). This Endothelin Receptor Antagonist market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
Global and China Endothelin Receptor Antagonist Market: Regional Segment Analysis
Global
China

The Major players reported in the market include:
Actelion Pharmaceuticals Ltd.
United Therapeutics Corporation
Gilead sciences
Bayer AG
SteadyMed Ltd.
GlaxoSmithKline plc
Pfizer Inc.
Reata Pharmaceuticals Inc.
Arena Pharmaceuticals Inc.

Global and China Endothelin Receptor Antagonist Market:Product Segment Analysis
Type 1
Type 2
Type 3

Global and China Endothelin Receptor Antagonist Market:Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
CHAPTER 1 ENDOTHELIN RECEPTOR ANTAGONIST MARKET OVERVIEW

1.1 Endothelin Receptor Antagonist Definition
1.2 Endothelin Receptor Antagonist Classification
1.3 Endothelin Receptor Antagonist Application
1.4 Endothelin Receptor Antagonist Industry Overview
  1.4.1 Global Endothelin Receptor Antagonist Sales and Growth Rate Forecast (2012-2022)
  1.4.2 China Endothelin Receptor Antagonist Sales and Growth Rate Forecast (2012-2022)

CHAPTER 2 GLOBAL AND CHINA ECONOMIC IMPACT ON ENDOTHELIN RECEPTOR ANTAGONIST INDUSTRY

2.1 Global Macroeconomic Environment Analysis
2.2 China Macroeconomic Environment Analysis

CHAPTER 3 GLOBAL ENDOTHELIN RECEPTOR ANTAGONIST COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

3.1 Global Endothelin Receptor Antagonist Market Competition by Manufacturers
  3.1.1 Global Endothelin Receptor Antagonist Sales and Market Share of Key Manufacturers (2012-2017)
  3.1.2 Global Endothelin Receptor Antagonist Revenue and Share by Manufacturers (2012-2017)
3.2 Global Endothelin Receptor Antagonist Sales and Revenue by Type
  3.3.1 Global Endothelin Receptor Antagonist Sales and Market Share by Type (2012-2017)
  3.3.2 Global Endothelin Receptor Antagonist Revenue and Market Share by Type (2012-2017)
3.3 Global Endothelin Receptor Antagonist Sales and Revenue by Application

CHAPTER 4 CHINA ENDOTHELIN RECEPTOR ANTAGONIST MARKET ANALYSIS

4.1 China Endothelin Receptor Antagonist Sales and Revenue (2012-2017)
  4.1.1 China Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
  4.1.2 China Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
  4.1.3 China Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
4.2 China Endothelin Receptor Antagonist Sales and Market Share by Manufacturers
4.3 China Endothelin Receptor Antagonist Sales and Market Share by Type
4.4 China Endothelin Receptor Antagonist Sales and Market Share by Application

CHAPTER 5 GLOBAL ENDOTHELIN RECEPTOR ANTAGONIST MANUFACTURERS ANALYSIS

5.1 Actelion Pharmaceuticals Ltd.
  5.1.1 Company Profile
  5.1.2 Product Type, Application and Specification
  5.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  5.1.4 Business Overview
5.2 United Therapeutics Corporation
  5.2.1 Company Profile
  5.2.2 Product Type, Application and Specification
  5.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  5.2.4 Business Overview
5.3 Gilead sciences
  5.3.1 Company Profile
  5.3.2 Product Type, Application and Specification
  5.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  5.3.4 Business Overview
5.4 Bayer AG
  5.4.1 Company Profile
  5.4.2 Product Type, Application and Specification
  5.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  5.4.4 Business Overview
5.5 SteadyMed Ltd.
  5.5.1 Company Profile
  5.5.2 Product Type, Application and Specification
  5.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  5.5.4 Business Overview
5.6 GlaxoSmithKline plc
  5.6.1 Company Profile
  5.6.2 Product Type, Application and Specification
  5.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  5.6.4 Business Overview
5.7 Pfizer Inc.
  5.7.1 Company Profile
  5.7.2 Product Type, Application and Specification
  5.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  5.7.4 Business Overview
5.8 Reata Pharmaceuticals Inc.
  5.8.1 Company Profile
  5.8.2 Product Type, Application and Specification
  5.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  5.8.4 Business Overview
5.9 Arena Pharmaceuticals Inc.
  5.9.1 Company Profile
  5.9.2 Product Type, Application and Specification
  5.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  5.9.4 Business Overview

CHAPTER 6 ENDOTHELIN RECEPTOR ANTAGONIST MANUFACTURING COST ANALYSIS

6.1 Endothelin Receptor Antagonist Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.3 Manufacturing Process Analysis of Endothelin Receptor Antagonist

CHAPTER 7 MARKET EFFECT FACTORS ANALYSIS

7.1 Technology Progress/Risk
  7.1.1 Substitutes Threat
  7.1.2 Technology Progress in Related Industry
7.2 Consumer Needs/Customer Preference Change
7.3 Economic/Political Environmental Change

CHAPTER 8 GLOBAL ENDOTHELIN RECEPTOR ANTAGONIST MARKET FORECAST (2017-2022)

8.1 Global Endothelin Receptor Antagonist Sales, Revenue Forecast (2017-2022)
8.2 Global Endothelin Receptor Antagonist Sales Forecast by Type (2017-2022)
8.3 Global Endothelin Receptor Antagonist Sales Forecast by Application (2017-2022)
8.4 Endothelin Receptor Antagonist Price Forecast (2017-2022)

CHAPTER 9 APPENDIX

LIST OF TABLES

Figure Picture of Endothelin Receptor Antagonist
Figure Global Sales Market Share of Endothelin Receptor Antagonist by Type in 2016
Table Endothelin Receptor Antagonist Sales Market Share by Application in 2016
Table Global Endothelin Receptor Antagonist Sales of Key Manufacturers (2015 and 2016)
Table Global Endothelin Receptor Antagonist Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Endothelin Receptor Antagonist Sales Share by Manufacturers
Figure 2016 Endothelin Receptor Antagonist Sales Share by Manufacturers
Table Global Endothelin Receptor Antagonist Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Endothelin Receptor Antagonist Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Endothelin Receptor Antagonist Revenue Share by Manufacturers
Table 2016 Global Endothelin Receptor Antagonist Revenue Share by Manufacturers
Table Global Market Endothelin Receptor Antagonist Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Endothelin Receptor Antagonist Average Price of Key Manufacturers in 2016
Table Manufacturers Endothelin Receptor Antagonist Manufacturing Base Distribution and Sales Area
Table Manufacturers Endothelin Receptor Antagonist Product Type
Figure Endothelin Receptor Antagonist Market Share of Top 3 Manufacturers
Figure Endothelin Receptor Antagonist Market Share of Top 5 Manufacturers
Table Global Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2012-2017)
Table China Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2012-2017)
Table Global Endothelin Receptor Antagonist Sales by Type (2012-2017)
Table Global Endothelin Receptor Antagonist Sales Share by Type (2012-2017)
Figure Sales Market Share of Endothelin Receptor Antagonist by Type (2012-2017)
Figure 2015 Sales Market Share of Endothelin Receptor Antagonist by Type
Table Global Endothelin Receptor Antagonist Revenue by Type (2012-2017)
Table Global Endothelin Receptor Antagonist Revenue Share by Type (2012-2017)
Figure Sales Revenue Share of Endothelin Receptor Antagonist by Type (2012-2017)
Figure 2015 Revenue Market Share of Endothelin Receptor Antagonist by Type
Table Global Endothelin Receptor Antagonist Price by Type (2012-2017)
Figure Global Endothelin Receptor Antagonist Sales Growth by Type (2012-2017)
Table Global Endothelin Receptor Antagonist Sales by Application (2012-2017)
Table Global Endothelin Receptor Antagonist Sales Market Share by Application (2012-2017)
Figure Global Endothelin Receptor Antagonist Sales Market Share by Application in 2016
Table Global Endothelin Receptor Antagonist Sales Growth Rate by Application (2012-2017)
Figure Global Endothelin Receptor Antagonist Sales Growth Rate by Application (2012-2017)
Figure China Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
Figure China Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
Figure China Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
Table China Endothelin Receptor Antagonist Sales by Manufacturers (2012-2017)
Table China Endothelin Receptor Antagonist Market Share by Manufacturers (2012-2017)
Table China Endothelin Receptor Antagonist Sales by Type (2012-2017)
Table China Endothelin Receptor Antagonist Market Share by Type (2012-2017)
Table China Endothelin Receptor Antagonist Sales by Application (2012-2017)
Table China Endothelin Receptor Antagonist Market Share by Application (2012-2017)
Table Actelion Pharmaceuticals Ltd. Profile
Table Actelion Pharmaceuticals Ltd. Endothelin Receptor AntagonistSales, Revenue, Price and Gross Margin (2012-2017)
Table Actelion Pharmaceuticals Ltd. Endothelin Receptor AntagonistMarket Share (2012-2017)
Table United Therapeutics Corporation Profile
Table United Therapeutics Corporation Endothelin Receptor AntagonistSales, Revenue, Price and Gross Margin (2012-2017)
Table United Therapeutics Corporation Endothelin Receptor AntagonistMarket Share (2012-2017)
Table Gilead sciences Profile
Table Gilead sciences Endothelin Receptor AntagonistSales, Revenue, Price and Gross Margin (2012-2017)
Table Gilead sciences Endothelin Receptor AntagonistMarket Share (2012-2017)
Table Bayer AG Profile
Table Bayer AG Endothelin Receptor AntagonistSales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer AG Endothelin Receptor AntagonistMarket Share (2012-2017)
Table SteadyMed Ltd. Profile
Table SteadyMed Ltd. Endothelin Receptor AntagonistSales, Revenue, Price and Gross Margin (2012-2017)
Table SteadyMed Ltd. Endothelin Receptor AntagonistMarket Share (2012-2017)
Table GlaxoSmithKline plc Profile
Table GlaxoSmithKline plc Endothelin Receptor AntagonistSales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline plc Endothelin Receptor AntagonistMarket Share (2012-2017)
Table Pfizer Inc. Profile
Table Pfizer Inc. Endothelin Receptor AntagonistSales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Inc. Endothelin Receptor AntagonistMarket Share (2012-2017)
Table Reata Pharmaceuticals Inc. Profile
Table Reata Pharmaceuticals Inc. Endothelin Receptor AntagonistSales, Revenue, Price and Gross Margin (2012-2017)
Table Reata Pharmaceuticals Inc. Endothelin Receptor AntagonistMarket Share (2012-2017)
Table Arena Pharmaceuticals Inc. Profile
Table Arena Pharmaceuticals Inc. Endothelin Receptor AntagonistSales, Revenue, Price and Gross Margin (2012-2017)
Table Arena Pharmaceuticals Inc. Endothelin Receptor AntagonistMarket Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Endothelin Receptor Antagonist
Figure Manufacturing Process Analysis of Endothelin Receptor Antagonist
Figure Endothelin Receptor Antagonist Industrial Chain Analysis
Table Raw Materials Sources of Endothelin Receptor Antagonist Major Manufacturers in 2016
Table Major Buyers of Endothelin Receptor Antagonist
Table Distributors/Traders List
Figure Global Endothelin Receptor Antagonist Sales and Growth Rate Forecast (2017-2022)
Figure Global Endothelin Receptor Antagonist Revenue and Growth Rate Forecast (2017-2022)
Table Global Endothelin Receptor Antagonist Sales Forecast by Type (2017-2022)
Table Global Endothelin Receptor Antagonist Sales Forecast by Application (2017-2022)

COMPANIES MENTIONED

Actelion Pharmaceuticals Ltd.
United Therapeutics Corporation
Gilead sciences
Bayer AG
SteadyMed Ltd.
GlaxoSmithKline plc
Pfizer Inc.
Reata Pharmaceuticals Inc.
Arena Pharmaceuticals Inc.
Merck & Co. Inc


More Publications